Are you ready skeedaddy???!!! It's time for the Lightning Round. Cramer makes the call on viewer favorites.» Read More
KANSAS CITY, Mo.-- Shares of Cerner Corp. soared in after-hours trading Thursday after the health care information management company said its third quarter net income increased 25 percent as bookings rose. Cerner predicted fourth-quarter revenue of $670 million to $700 million, and adjusted profit of 62 to 64 cents per share.
U.S. stocks rose at the open after labor market data came in within expectations and following encouraging comments by European Central Bank President Mario Draghi on tools to tackle the region's debt crisis. **NUVASIVE INC, $14.9, down 34 pct.
U.S. stock index futures added to gains after European Central Bank President Mario Draghi said growth risks are on the downside and should be contained by effective policymaker action. Brokerages Canaccord Genuity, Robert W. Baird& Co, Mizuho Securities USA, BMO Capital Markets and ThinkEquity Llc cut their price targets on the stock.
U.S. stock index futures added to gains after European Central Bank President Mario Draghi said growth risks are on the downside and should be contained by effective policymaker action. **NUVASIVE INC, Wednesday close $22.62, down 29.3 pct premarket. **INFORMATICA CORP, Wednesday close $33.63, down 19.7 pct premarket.
U.S. stock index futures pointed to a higher open on Wall Street on Thursday, with futures for the S&P 500, the Dow Jones and the Nasdaq 100 rising between 0.2 and 0.5 percent. **NUVASIVE INC, Wednesday close $22.62, down 27.4 pct premarket.
*Jefferies starts Cerner Corp with hold rating. Reuters Station users, click. 1568. Reuters Station users, click. 4899.
NEW YORK-- Shares of Allscripts Healthcare Solutions Inc. continued to rise Monday as Wall Street evaluated a report that the electronic health records company may sell itself to a private buyer. THE SPARK: Bloomberg News reported Friday that Allscripts is considering a sale and had engaged Citigroup Inc. as it considered its options.
Looking for trades that are about to heat up? Summer may be the right season for the following 4 stocks.
Given tech’s market leadership this year and the emerging comparisons to the crisis of several years ago, we rounded up the 10 best performance tech ETFs over the past three years.
Human Genome Sciences is one of the reasons the NYSE Arca Biotech Index is having its best day since December 2010.
We may still be listening to Madonna today – who topped the charts with “Like a Prayer” in 1989 – but time has not stood still for your money.
Cramer makes the call on viewers' favorite stocks.
Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!
It's the basic question when investing in a stock: is it on the way up or will it go down? Wall Street has developed numerous ways of attempting to predict what will happen.
The “Mad Money” host admits he made a mistake, and now recommends a different name in the health care information technology wars.
Mad Money's Cramer explains why the best way to play the expansion of electronic medical records is to sell Allscripts and swap into Cerner, the next time the stock gets pulled down with the rest of the market.
Technology stocks have been gaining momentum in 2012, up eight of the last nine weeks. However, over the last 12 months, consumer discretionary and health care companies have really powered the rally.
Caesars Entertainment is among several companies showing unusual movement in Wednesday's trading session.
When it comes to combating financial markets that all seem to move in unison, the options are getting so limited that some are questioning whether stock picking is a dying art.
Expected government cuts to Medicare and Medicaid, the uncertainty of health care reform and looming patent expirations are weighing heavily on the outlook of the biggest companies in the sector: large-cap pharmaceutical stocks.